Virginia Marin-Martinez

NKGD2 Ligands (NKG2DLs) in Breast Cancer: In Silico Analysis and Narrative Review.

Journal: International journal of molecular sciences

Published: January 26, 2026

Cancer-associated venous thromboembolism and its impact on survival in the ONCOTHROMB12-01 cohort study.

Journal: International journal of cardiology. Heart & vasculature

Published: April 03, 2025

Unscheduled hospitalization as a potential trigger for specialist palliative care referral in patients with high grade glioma: a retrospective analysis in a tertiary hospital.

Journal: Journal of neuro-oncology

Published: January 30, 2025

Proton pump inhibitors decrease efficacy of palbociclib in patients with metastatic breast.

Journal: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners

Published: August 02, 2024

Beyond cancer treatment: dermo-aesthetic and other wellness recommendations for breast cancer patients.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: April 09, 2024

Evaluation of the clinical use of MGMT methylation in extracellular vesicle-based liquid biopsy as a tool for glioblastoma patient management.

Journal: Scientific reports

Published: January 08, 2024

MiR-151a: a robust endogenous control for normalizing small extracellular vesicle cargo in human cancer.

Journal: Biomarker research

Published: July 27, 2023

REGISTRI: Regorafenib in first-line of KIT/PDGFRA wild type metastatic GIST: a collaborative Spanish (GEIS), Italian (ISG) and French Sarcoma Group (FSG) phase II trial.

Journal: Molecular cancer

Published: June 08, 2023

SEOM-GEIS clinical guideline for gastrointestinal stromal tumors (2022).

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: March 23, 2023

A Clinical-Genetic Risk Score for Predicting Cancer-Associated Venous Thromboembolism: A Development and Validation Study Involving Two Independent Prospective Cohorts.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: February 02, 2023

NKGD2 Ligands (NKG2DLs) in Breast Cancer: In Silico Analysis and Narrative Review.

NKGD2 Ligands (NKG2DLs) in Breast Cancer: In Silico Analysis and Narrative Review.

Cancer-associated venous thromboembolism and its impact on survival in the ONCOTHROMB12-01 cohort study.

Cancer-associated venous thromboembolism and its impact on survival in the ONCOTHROMB12-01 cohort study.

Unscheduled hospitalization as a potential trigger for specialist palliative care referral in patients with high grade glioma: a retrospective analysis in a tertiary hospital.

Unscheduled hospitalization as a potential trigger for specialist palliative care referral in patients with high grade glioma: a retrospective analysis in a tertiary hospital.

Proton pump inhibitors decrease efficacy of palbociclib in patients with metastatic breast.

Proton pump inhibitors decrease efficacy of palbociclib in patients with metastatic breast.

Beyond cancer treatment: dermo-aesthetic and other wellness recommendations for breast cancer patients.

Beyond cancer treatment: dermo-aesthetic and other wellness recommendations for breast cancer patients.

Evaluation of the clinical use of MGMT methylation in extracellular vesicle-based liquid biopsy as a tool for glioblastoma patient management.

Evaluation of the clinical use of MGMT methylation in extracellular vesicle-based liquid biopsy as a tool for glioblastoma patient management.

MiR-151a: a robust endogenous control for normalizing small extracellular vesicle cargo in human cancer.

MiR-151a: a robust endogenous control for normalizing small extracellular vesicle cargo in human cancer.

REGISTRI: Regorafenib in first-line of KIT/PDGFRA wild type metastatic GIST: a collaborative Spanish (GEIS), Italian (ISG) and French Sarcoma Group (FSG) phase II trial.

REGISTRI: Regorafenib in first-line of KIT/PDGFRA wild type metastatic GIST: a collaborative Spanish (GEIS), Italian (ISG) and French Sarcoma Group (FSG) phase II trial.

SEOM-GEIS clinical guideline for gastrointestinal stromal tumors (2022).

SEOM-GEIS clinical guideline for gastrointestinal stromal tumors (2022).

A Clinical-Genetic Risk Score for Predicting Cancer-Associated Venous Thromboembolism: A Development and Validation Study Involving Two Independent Prospective Cohorts.

A Clinical-Genetic Risk Score for Predicting Cancer-Associated Venous Thromboembolism: A Development and Validation Study Involving Two Independent Prospective Cohorts.

Efficacy of second and third lines of treatment in advanced soft tissue sarcomas: a real-world study.

Efficacy of second and third lines of treatment in advanced soft tissue sarcomas: a real-world study.

2023 GEIS Guidelines for gastrointestinal stromal tumors.

2023 GEIS Guidelines for gastrointestinal stromal tumors.